Literature DB >> 3699396

Eradication of esophageal varices with repeated injection sclerotherapy in inoperable patients.

S Kitano, K Nagamine, T Iwanaga, K Beppu, N Koyanagi, Y Iso, K Sugimachi.   

Abstract

Esophageal varices in 50 cirrhotic patients were treated with repeated injection sclerotherapy. Eradication of varices was achieved in 27 patients (54.0%) with a mean of 4.5 injections (range 2-12) after a mean period of 3.1 months (range 1-11). There was no variceal bleeding in these 27 patients once eradication had been achieved, with a mean follow up period of 5.6 months, although bleeding occurred in 5 of the same group before eradication of the varices had been achieved, during an average of 3.1 months, and in 6 of the remaining 23 patients (10 episodes) with residual varices after a mean of 4.7 injections (range 2-12) in a mean period of 12.2 months (range 1-33). Esophageal varices can thus be eradicated with repeated injections and bleeding from recurrent esophageal varices can be prevented in many patients after eradication has been achieved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699396     DOI: 10.1007/bf02775933

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  14 in total

1.  Further evaluation of the Sugiura procedure in the treatment of esophageal varices.

Authors:  M Sugiura; S Futagawa
Journal:  Arch Surg       Date:  1977-11

2.  New selective decompression of esophageal varices. By a left gastric venous-caval shunt.

Authors:  K Inokuchi; M Kobayashi; A Kusaba; Y Ogawa; M Saku; T Shiizaki
Journal:  Arch Surg       Date:  1970-02

3.  Present status of surgical treatment of esophageal varices in Japan: a nationwide survey of 3,588 patients.

Authors:  K Inokuchi
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

4.  Factors affecting successful endoscopic sclerotherapy for oesophageal varices.

Authors:  J D Rose; M D Crane; P M Smith
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

5.  Endoscopic sclerotherapy for esophageal varices. Health and Public Policy Committee, American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

6.  A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices.

Authors:  J Terblanche; J M Northover; P Bornman; D Kahn; G O Barbezat; S L Sellars; S J Saunders
Journal:  Surgery       Date:  1979-03       Impact factor: 3.982

7.  Ten years' experience with mesocaval grafts.

Authors:  J B Dowling
Journal:  Surg Gynecol Obstet       Date:  1979-10

8.  The natural history of non-alcoholic cirrhosis.

Authors:  M Hashizume; K Inokuchi; K Beppu; N Koyanagi; K Nagamine; K Sugimachi; S Hirose
Journal:  Gastroenterol Jpn       Date:  1984-10

9.  Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis.

Authors:  M J Orloff; R H Bell; P V Hyde; W P Skivolocki
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

10.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

Authors:  K J Paquet
Journal:  Endoscopy       Date:  1982-01       Impact factor: 10.093

View more
  3 in total

1.  Prediction of the recurrence of esophageal varices based on portal vein pressure and oxygen tension in portal and peripheral blood.

Authors:  K Obara; H Sakamoto; R Kasukawa
Journal:  Gastroenterol Jpn       Date:  1991-12

2.  Endoscopic injection sclerotherapy using a transparent overtube with intraluminal negative pressure (np-EIS) for esophageal varices.

Authors:  T Kawano; H Nakamura; H Inoue; M Endo
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

3.  A transparent over-tube for endoscopic injection sclerotherapy and results in patients with esophageal varices.

Authors:  S Kitano; T Iwanaga; Y Iso; N Koyanagi; K Sugimachi
Journal:  Jpn J Surg       Date:  1987-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.